Cough suppression therapy via group telehealth
Part of Lungs & breathing clinical trials.
This study tests a behavioral therapy delivered through group video calls to help people with a chronic dry cough that has no clear cause. It may offer a non-drug way to reduce coughing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had a dry cough for at least 8 weeks.
- You have seen at least one doctor for your cough.
- You had a chest X-ray or CT scan related to your cough that came back normal.
- You have a computer or tablet with a camera and can use it on your own.
- You have reliable internet access.
- You do not currently smoke or have a smoking history of 10 or more years.
- You are not coughing up blood.
- You do not have a chronic lung disease (like COPD, asthma that has been formally diagnosed, or lung cancer).
- You do not have difficulty swallowing.
- You are not taking certain blood pressure medicines (ACE inhibitors) that can cause coughing.
- You have not had prior cough suppression therapy by a speech-language pathologist or respiratory therapist.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a behavior-based therapy to help you gain control over a persistent cough that hasn't responded to other treatments. You will learn techniques to reduce coughing during a 4-week program.
This trial tests a smartphone app and a smartwatch to help people with chronic cough that hasn't improved with standard care. You'll wear a watch to track your cough and use the app to learn management techniques.
This 24-week study tests whether a new medicine called BLU-5937 can help adults whose chronic cough hasn't improved with standard treatments. Chronic cough that lasts a year or longer can seriously affect quality of life, and this trial explores whether this drug might provide relief.
This trial tests a new medicine, HW091077, for people who have had a chronic cough for at least a year that hasn't gotten better with treatment or has no clear cause. It aims to see if the drug can help reduce coughing.
This Phase 2 study tests whether two doses of duloxetine and amitriptyline can reduce symptoms in people with chronic cough that hasn’t responded to usual care. You may join to see if these medicines lessen cough severity over an 8-week blinded treatment period.
This trial tests whether an extended-release medication called nalbuphine can reduce coughing in people with chronic cough that hasn't improved with other treatments. You may be eligible if you've had a persistent cough for at least a year and have already tried treatments for conditions that could cause it.
Hear when a new Refractory Chronic Cough trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.